PHARMACEUTICAL PREPARATION AND TOXICOLOGICAL STUDY OF RASA BHASMA by Prasad, Yerranaagu et al.
           Int. J. Ayur. Pharma Research, 2013; 1(2): 38-48                         ISSN 2322 - 0910 
 
 Available online at : http://ijapr.in Page 38 
 
International Journal of Ayurveda and Pharma Research  
                                            Research Article 
PHARMACEUTICAL PREPARATION AND TOXICOLOGICAL STUDY OF RASA BHASMA 
 Yerranaagu Prasad1*, P.H.C. Murthy2, B. Dinesh Kumar3 
1*P.G. Scholar, 2Guide, I/C. Professor and H.O.D., P.G. Dept. of Rasashastra, Dr. N.R.S. Govt. Ayurvedic College, 
Vijayawada, Andhra Pradesh, India. 
3Co-Guide, Asst. Director, Food & Drug Toxicology Research Centre, National Institute of Nutrition, (Indian Council 
of Medical Research), Tarnaka, Hyderabad, Andhra Pradesh, India. 
 
ABSTRACT 
The traditional use of Ayurvedic formulations is a widely accepted therapeutic option especially 
in chronic diseases. The quality of Bhasma depends on the manufacturing procedures and dosage 
schedule mentioned as per the classical texts. The Ayurvedic formulations are being considered as 
therapeutic potential agent as they have been evaluated based on experimental analysis. However 
for global acceptance the safety is a concern, the WHO has recognized Ayurveda as a part of 
integrated system of medicine. In view of developments an investigation is undertaken to evaluate 
the safety of a Bhasma. Rasa Bhasma, an organo-metallic compound is one such compound 
described in Rasa Shastra for treating acute and chronic diseases. It is prepared in several steps, 
which increases its therapeutic potential and eliminates its metallic toxicity. Among the various 
Bhasma preparations a popularly recommended and used formulation of Rasa Bhasma was 
selected for the toxicology study. In the present investigation it is proposed to undertake a short 
term pre clinical acute toxicity test on Rats, to obtain the safety profile. The proposed experiment 
has been under taken after taking the approval of Institutional Approval Ethical Committee, SIPRA 
Labs to conduct the experiment at their centre. Acute toxicity study on 15 Swiss Albino Rats, have 
been randomizingly selected and divided into two groups to receive the test compound in a 
vehicle and identified as a TD and a vehicle group to receive Honey, Water for a period of 7 days 
and identified as VC. 8 (3VC+5TD) animals after 48 hours and remaining 7(2VC+5TD) animals 
after 7 days were subjected for haematology, clinical chemistry and necropsy observation. After 7 
days of exposure to the test compound of recommended therapeutic dose, no significant changes 
in haematological parameters & clinical chemistry parameters were found. No Pre-terminal 
deaths occurred in rats, which received test compound at therapeutic dose levels. No 
abnormalities in physical, physiological, clinical chemistry, hematological parameters and no 
gross necropsy changes were observed on administration (oral) of test compound prepared 
according to the classical literature. At this level of study, it may be concluded that Rasa Bhasma is 
safe as per toxicological study and can be subjected for further study of clinical evaluation. 
KEY WORDS: Rasa Bhasma, Toxicological study, Hematological parameters. 
INTRODUCTION 
A careful scrutiny of the Rasatantric texts 
would reveal that almost all the treatises on 
Rasashastra contain references related to Parada 
Marana. However, these references a ‘Rasasadhaka’ 
may make his mind in selecting a suitable procedure 
for Parada Marana. A planning for evaluation of these 
methods regarding their perfectness as well as 
planning in the sphere of research can also be worked 
out. To facilitate for such a planning it is obvious that 
all such references should be compiled at one place 
and scrutinised scientifically and carefully. There are 
many more methods in the published treatises on 
Rasashastra. It is quite possible that various 
unpublished and unnoticed manuscripts on 
Rasashastra will have some more methods of 
preparation of Parada Bhasma. In various traditions 
also, it is possible that various methods of Parada 
Bhasma preparations will prevail which traditional 
Rasa Sadhakas who are hardeners never disclose. 
Wherever the methods of Parada Bhasma preparations 
are described scientific explanation or the explanation 
of the interaction between the ingredients or the 
changes undergone through various processes have 
been made. The compilation has been classified in all 
five categories have been made based on the colour of 
Parada Bhasma. 
Specification of Colour 
1. White coloured Parada Bhasma 
2. Red coloured Parada Bhasma 
3. Yellow coloured Parada Bhasma 
4. Black coloured Parada Bhasma 
5. Parada Bhasma of unspecified colour. 
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Properties of Parada Bhasma 
 A careful screening of the Rasatantric 
literature would reveal that various types of 
therapeutic effects and pharmacological actions of 
Parada Bhasma have been mentioned by various 
authorities. Though the consideration of these 
pharmacological or therapeutic properties does not 
make the part of the present study, even then it will 
provide a background for future worker on this 
subject.  
Rasa Bhasma is prepared in 2 methods, one is 
taken from Rasa Manjari and the other is taken from 
Khanija Bhasmarajam. Three methods were followed 
for mercury purification and purified mercury is 
named as M1, M2 and M3 from which they obtained 
Rasa Bhasma named respectively RB 1 to RB 6, and 
processing has been divided into following steps. 
Method-I 
A. Shodhana of raw materials 
i. Parada 
ii. Gandhaka 
B. Preparation of Kajjali and Bhavana with 
Grhitakumari 
C. Preparation of Samputayantra and Bhudhara 
Yantra 
Method-II 
A. Shodhana of raw materials 
i. Parada 
ii. Vanga 
B. Preparation of Baddha Parada 
C. Preparation of Samputa and Puta 
MATERIALS AND METHODS 
1. Preparation of Rasa Bhasma 
2. Purification of raw material 
3. Preparation of Kajjali 
4. Toxicological Study 
Method-I: 
1. Shodhana (purification) of Parada: 
 Purification of Parada was carried out with 
three different procedures from various texts such as 
Rasatarangini, Rasa Ratnakar Riddhikhand and from 
Bharata Bhaisajya Ratnakar.  
Procedure-1 
 1 kg of Parada was taken with 1 kg of Chuna 
(lime powder) in granite Khalva and trituration was 
done for eight hours in a day for 3 days. After complete 
trituration it was filtered through a double folded cloth 
to obtain the Parada. Because of its heaviness, Parada 
passed through the cloth and lime powder retained. 
Thus obtained Parada was filtered by a cloth. Thus, the 
clear 980 gm.. of Parada was obtained. 
 Obtained Parada was taken into a Khalva 
yantra and equal quantity of garlic paste (980 gm.) and 
half the amount of Saindhava lavana (490 gm.). are 
added. Trituration was again applied until whole 
mixture became black colour (paste of garlic). The 
washing and decanting was applied with the help of 
hot water for several times to get a clear Parada (920 
gm.). Parada so obtained was completely pure[1]. All 
types of blemishes, which it had in the beginning are 
now removed through the process.  
PROCEDURE-2 
 250g. of Hingula was taken in Khalva and was 
made powdered, added lemon juice as Bhavana dravya 
and triturated continuously for 8 hrs. In between the 
process citrus juice was added whenever necessary. 
After triturating Hingula paste is applied in inner 
bottom part of Ghata and was made Urdhvapatana 
Yantra. It was heated on Vidhyadhara Yantra with mild 
(3000C), moderate (4000C) and intensive (6000C) Agni 
for 6 hours. In intensive period (last 2 hours) cold pads 
were kept over the top of the Urdhvapatana Yantra. 
After that left the Yantra for getting self-cooling. (Rasa 
Ratnakara Riddhikhanda. 2/53) 
 Next day, seal was removed carefully and 
Parada was collected by rubbing with brush at the 
Parada containing surface of the upper utensil, and 
filtered it by clean cotton cloth. 160 g. of Parada was 
obtained in this procedure. 
PROCEDURE-3 
 1 kg. of Parada was taken in Khalva, 1 kg. of 
garlic paste was added to the mercury, triturated for 8 
hrs. It was washed with hot water and filtered through 
double folded cloth. Obtained Parada (810 gm.) was 
again triturated with juice of betel leaf for 8 hrs, 
washed with hot water and filtered. 780 gm. of 
obtained Parada again triturated with Triphala 
decoction (3 myrobalans), washed with hot water and 
filtered. The weight of Parada thus obtained was 720 
gms[2]. 
Sodhana (Purification) of Gandhaka 
 2 lit. of milk was boiled and taken in a vessel, 
the mouth of the vessel was covered with a clean cloth 
piece and tied around. 500 gm. of Gandhaka was 
melted with Sarshapa (mustard) oil in an iron spoon 
and immediately poured into the milk through the 
cloth. 
 The Gandhaka on cooling was collected from 
the vessel, in the form of large granules. It was washed 
with warm water, dried and then powdered[3]. 
Importance of usage of Taptakhalva in Parada 
Samskara 
 Nityanatha Siddha mentioned in his Rasa 
Ratnakara Riddhi Khanda in second chapter to use the 
Tapta Khava. He revealed that it is ideal to use 
Taptakhalva in Mardana, Shodhana, Charana, Jarana, 
Murchana, Bandhana and Marana of Parada 
(R.R.Ri.2/45). It is also stated that Loha Kharal (Iron 
mortor) is ideal for the Taptakhara; and in the absence 
of Loha Kharal we can use stone kharal (R.R.Ri.2/47). 
Preparation of Kajjali 
Kajjali was the chief source of this procedure. 
Therefore, Kajjali was prepared at first. 
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 The purified mercury and sulphur alone or in 
combination with other metals/drugs recommended 
in the compound are triturated without liquids so as to 
be converted into a smooth, blackish powder, free 
from any shining. It is known as Kajjali[4].  
Ingredients 
a.  Purified Parada – 100 gm. (Each M1, M2, M3 
separately) 
b. Purified Sulphur – 50 gm. 
Method of preparation 
1. In this procedure, Kajjali was prepared 3 times with 
purified mercury M1, M2, M3 and sulphur, and 
obtained Kajjali was named as K1, K2, K3. 
2. Purified mercury and sulphur were taken in 2:1 
ratio and were put in an iron mortar (Taptakalva) 
and grinded well. 
3. The grinding was continued until the total mixture 
is converted into a fine, black, smooth, tasteless 
powder.  
4. Weight of prepared Kajjali K1, K2 and K3 are 
respectively 140 gm. 138 gm. and 135 gm. 
PREPARATION OF RASA BHASMA 
Requirements 
 Kajjali K1- 140 gm. 
K2 – 138 gm. 
K3 – 135 gm. 
 Ghrita Kumari (Aloe vera) Swarasa – q.s. 
 Apparatus used – Khalva, musal, Bhudara Yantra 
etc. 
Bhudara Yantra 
 The pit was made in the earth with the 
measurements of 6 inches of depth and 8 inches of 
width. The pit was filled with sand upto 2 inches and 
Samputa Yantra was placed on the sand and the total 
pit was filled with the sand. On the surface of the sand 
cow dung cakes were placed and subjected to heat 
continuously for 8 hrs.  
Process 
 Kajjali was taken in Khalva, added with 
Kumari Svarasa (juice of Aloe vera L.) as Bhavana 
dravya and triturated for 8 hrs. Then made into bolus 
and dried in the sunlight. The bolus was named as B1, 
B2, B3 and its weights were 200 gm. 190 gm. 193 gm. 
respectively. These bolus were kept into Samputa 
Yantra, seal both edges of the vessels and dried in 
sunlight. The Samputa Yantra (S1, S2, S3) were kept in 
Bhudhara Yantra and subjected to heat continuously 
for 8 hrs. After Svangashita the Samputa Yantras were 
taken out, the boluses were crushed into powder, and 
obtained Rasa Bhasma were named as RB1, RB2 and 
RB3. (Rasa Manjari /11) 
 
 
Result 
Weight of Rasa Bhasma 1 – 125 gm. 
Weight of Rasa Bhasma 2 – 120 gm. 
Weight of Rasa Bhasma 3 – 110 gm. 
VANGA SODHANA 
Procedure 
1 kg. of Vanga (tin) is taken into an iron 
cauldron and heated over moderate fire till the 
complete Vanga is melted. This melted Vanga is 
poured into limewater and allowed to settle. This is 
taken out of limewater and washed off to remove 
crystals or sediments of lime deposited over it. For 
proper purification of Vanga, the process of Dhalana 
was carried out seven times[5]. 
Process 
No. 
Quantity 
of Vanga 
taken 
Quantity 
obtained 
Loss 
during 
the 
process 
1. 1000 gm. 990 gm. 10 gm. 
2. 990 gm. 985 gm. 5 gm. 
3. 985 gm. 970 gm. 15 gm. 
4. 970 gm. 960 gm. 10 gm. 
5. 960 gm. 945 gm. 15 gm. 
6. 945 gm. 920 gm. 25 gm. 
7. 920 gm. 895 gm. 25 gm. 
Net weight of Sodhita Vanga obtained – 895 gm. 
Preparation of Rasa Bhasma 
Date of commencement: 25-8-2006  
Date of completion: 15-09-2006 
Ref: Khanija Bhasma Rajam, Page No.105 
Process 
 50 gm. of purified Vanga was taken in an iron 
spoon, kept on fire and 50 gm. of purified mercury was 
added to the melted Vanga, mixed and poured into the 
earthen pot filled with 100 gm. of ghee. 
 After cooling, solidified Vanga mixed Parada 
was obtained from the ghee, then made into seven 
pieces, 125 gm. of Dugdhika powder was taken in a 
cloth, placed these seven places of Vanga mixed 
Parada powder and spread over with 125 gm. of 
Dugdhika powder and corners of the cloth. It was 
rolled and applied 12 layers of mud pasted cloth and 
dried. Then it was subjected to Puta with 300 cow 
dung cakes (each 50 gm. weight), on the next day, 
Samputa was collected from Puta and Rasa Bhasma 
and Vanga were separated. 
 The same procedure was done three times 
with 50 gm. of purified mercury M1, M2 and M3 each 
time respectively. 
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RESULT 
Weight of Rasa Bhasma RB4 = 4 gm. 
             Rasa Bhasma RB5 = 0 gm. 
            Rasa Bhasma RB6 = 0 gm. 
Weight of remained Vanga V1 = 50 gm. 
     V2 = 50gm. 
     V3 = 50 gm. 
RASA BHASMA – ACUTE TOXICITY TEST 
In the present investigation, it is proposed to 
undertake a short-term pre clinical acute toxicity test 
on Rats to obtain the safety profile. 
MATERIALS AND METHODS 
Test compound 
Among the various Bhasma preparations, a 
popularly recommended and used formulation Rasa 
Bhasma 2 has been selected.  
 Dosage schedule:  
Dose (clinical)       : 120 mg/day/Adult 
Duration      : 3-4 Weeks 
Route       : oral 
Dosage experiment : 10.8 mg/kg 
Duration      : 7 days 
Route       : oral  
Vehicle       :  Honey & Water (3:2) 
IAEC approval  
The proposed experiment has been under 
taken after taking the approval of Institutional Approval 
Ethical Committee, SIPRA Labs to conduct the 
experiment at their centre.  
Species 
 Swiss Albino (I.B) Rat have been obtained 
from registered breeder. The initial weights were 
recorded and conditioned for 5 days to initiate the 
experiment. 
Housing 
Animals were housed in groups of two in 
standard suspended polycarbonate cages with top grill 
having facilities for pelleted feed and drinking water in 
glass bottles with stainless steel sipper tubes. The 
bottom of the cage was also stainless steel grilled to 
facilitate free dropping of feces and urine to prevent 
coprophagy. 
Husbandry 
The environmental conditions were maintained 
at 21 ± 2°C, with 10 – 15 air changes per hour and 
relative humidity of 50 – 55% with a 12 hour light/dark 
cycle.  
Feed and Water  
The animals had free access to sterile pelleted 
feed of standard composition containing all macro and 
micronutrients. Water that was passed through 
activated charcoal filter and exposed to UV rays (Aqua 
guard on-line water filter-cum-purifier) was provided.  
Age at start of treatment  
4 - 6 weeks  
Body weight range at the start of the experiment  
Rats having body weight of 120 – 150 gm. 
were selected for the acute study.  
Animal Identification 
Animals receiving the same treatment were 
housed in groups of two with appropriate identification 
(label) on cages. Animals in each cage were identified by 
standard ear marking (Right cut, Left cut & No cut for 3 
animals) and (Right cut, Left cut for 2 animals) 
procedures for rats and by the labels on the cage. The 
Unique ID no’s were given. In addition, cage cards were 
also marked.  
Study design  
Since it is a acute toxicity study 15 Rats have 
been randomizingly selected and divided into two 
groups to receive the test compound in a vehicle and 
identified as a TD and a vehicle group to receive 
Honey, Water for a period of 7 days and identified as 
VC. (Table No.1)  
Table 1: Test groups  
S.No Test Group Duration of 
Exposure 
Study Parameters 
48 Hrs after last exposure 7 Days after Last Exposure 
1 Vehicle 
Control  
(05) 
7 Days Hematology 
Biochemistry 
Necropsy Findings (03) 
Hematology 
Biochemistry 
Necropsy Findings (02) 
2 Test group 
(10) 
7 Days Hematology 
Biochemistry 
Necropsy Findings (05) 
Hematology 
Biochemistry 
Necropsy Findings (05) 
( ) = No of animals 
The animals were observed for lethality and mortality after test compound exposure followed by daily 
observation for 14 days.  
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i. The Pre-terminal deaths if were recorded every day till 14th day of the test compound exposure.  
ii. In case of death of any animal during the observation period the autopsy were proposed to collect all vital 
organs like brain, liver, kidney, heart, lung, productive organs, intestine will be collected for studying 
histopathological changes.  
iii. 8 (3VC+5TD) animals after 48 hours and remaining 7(2VC+5TD) animals after7 days of last were subjected 
for haematology, clinical chemistry and necropsy observation.  
Table 2: Dosage Schedule (RAT) 
S.No Group details  Human dose 
in mg per day 
Compound details + Dosage schedule* per 200 gm rat / day 
Strength mg / 1ml Strength mg / kg 
1. Vehicle Control - Sterile distilled water 
and honey (2:3)  
HW 
2. Therapeutic 
dose  
120 RB2 + HW 4.32mg 10.8 mg. 
* Route of administration = oral 
 * volume of administration = 0.5ml 
Table 3: Mortality & Body Weights of Rats in acute study 
 S. No Pre-terminal 
deaths 
Activity Animal Body Weights (gm) 
1st day 4th day 8th day 11th day 14th day 
1 X 1 141.7 154 160.0 E E 
2 X 1 137.6 151 157.0 E E 
3 X 1 136.3 154 159.0 E E 
4 X 1 139.3 153 158.0 163 169 
5 X 1 149.3 163 16.6 172 180 
6 X 1 140.1 142 149.0 E E 
7 X 1 134.5 140 149.0 E E 
8 X 1 121.5 130 135.0 E E 
9 X 1 118.1 124 125.0 E E 
10 X 1 138.4 155 163.0 E E 
11 X 1 130.0 149 154.0 158 159 
12 X 1 131.4 150 146.0 148 149 
13 X 1 119.0 142 144.0 147 145 
14 X 1 148.5 158 174.0 178 181 
15 X 1 133.7 137 149.0 152 151 
* 1 – Active, 2 – Inactive    E -- Euthenised 
Table 4: Live phase of animals 
Groups Days* General behaviour Water intake 
Active Not active Adequate Inadequate 
VC Baseline 100 %  Nil 100 %  Nil 
7 100 %  Nil 100 %  Nil 
14 100 %  Nil 100 %  Nil 
TD (1X) Baseline 100 %  Nil 100 %  Nil 
7 100 %  Nil 100 %  Nil 
14 100 %  Nil 100 %  Nil 
Table 5: Cage Side Observation 
Groups  Days Home cage activity (%)  
Lying on 
side  
Resting  Sitting  Alert & oriented towards 
investigator  
Circling 
purposelessly 
VC  Baseline Nil 70 % 30 % Nil Nil 
7 Nil 60 % 40 % Nil Nil 
14 Nil 100 % Nil % Nil Nil 
TD (1X) Baseline Nil 60 % 40 % Nil Nil 
7 Nil 70 % 30 % Nil Nil 
14 Nil 100 % Nil Nil Nil 
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Table 6: Cage Side Observation (Contd..) 
Groups  Days 
Feces output (%) Feces consistency (%)  
Normal  Abnormal  Normal  Abnormal  
VC 
Baseline 100 % Nil 100 % Nil 
7 100 % Nil 100 % Nil 
14 100 % Nil 100 % Nil 
TD (1X) 
Baseline 100 % Nil 100 % Nil 
7 100 % Nil 100 % Nil 
14 100 % Nil 100 % Nil 
Table 7: Cage Side Observation (Contd..) 
Groups  Days 
Urine output (%)  Urine colour (%)  
Normal  Abnormal  Normal  Abnormal  
VC  
Baseline 100 % Nil 100 % Nil 
7 100 % Nil 100 % Nil 
14 100 % Nil 100 % Nil 
TD (1X) 
Baseline 100 % Nil 100 % Nil 
7 100 % Nil 100 % Nil 
14 100 % Nil 100 % Nil 
Table 8: Cage Side Observation (Contd.) 
Groups  Days 
Behaviour while removal from cage (%) 
Animal quiet easily 
removed 
Runs around 
cage  
Orient towards 
investigator  
Aggressive Vocalisation 
VC  
Baseline Nil 100 % Nil Nil Nil 
7 80 % 10 % Nil 10 % Nil 
14 100 % Nil Nil Nil Nil 
TD 
(1X) 
Baseline 10 % 90 % Nil Nil Nil 
7 90 % 10 % Nil Nil Nil 
14 90 % 10 % Nil Nil Nil 
Table 9: Physical Examination 
Groups  Days Hair coat (%)  Piloerection (%)  Respiratory rate (%) 
Clean groomed Slightly soiled  Normal Abnormal  Normal  Increased 
VC  Baseline 100 % Nil 100 % Nil 100 % Nil 
7 100 % Nil  100 % Nil  100 % Nil  
14 100 % Nil  100 % Nil  100 % Nil  
 
TD (1X) 
Baseline 100 % Nil 100 % Nil 100 % Nil 
7 100 % Nil 100 % Nil 100 % Nil 
14 100 % Nil 100 % Nil 100 % Nil 
Table 10: Physical Examination (Contd..) 
Groups  Days 
Res. character (%)  Lacrimation (%)  Salivation (%)  
Normal  Abnormal  None  None  
VC  
Baseline 100 % Nil 100 % 100 % 
7 100 % Nil  100 % 100 % 
14 100 % Nil  100 % 100 % 
 
TD (1X) 
Baseline 100 % Nil 100 % 100 % 
7 100 % Nil 100 % 100 % 
14 100 % Nil 100 % 100 % 
Table 11: Physical Examination (Contd..) 
Groups  Days Eye prominence (%)  Eye lid (s) closure (%)  
Normal  Abnormal  Wide open 
VC  Baseline 100 % Nil 100 % 
7 100 % Nil 100 % 
14 100 % Nil 100 % 
 
 
TD (1X) 
Baseline 100 % Nil 100 % 
7 100 % Nil 100 % 
14 100 % Nil 100 % 
  ( ) No of animals 
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Table 12: Physical Examination (Contd..) 
Groups  Days Convulsions (%)  Biting (%)  Tremors (%)  
None  None  None  Body tremors only  
VC  Baseline 100 % 100 % 100 % Nil 
7 100 % 100 % 100 % Nil 
14 100 % 100 % 100 % Nil 
 
 
TD (1X) 
Baseline 100 % 100 % 100 % Nil 
7 100 % 100 % 100 % Nil 
14 100 % 100 % 100 % Nil 
 ( ) No of animals 
Table 13: Neurological Examination 
Groups  Days Locomotor activity (%) Rearing Activity (%) 
Resting 
 
Scratching 
casually 
Did not rear 
 
Rear on hind limbs 
with the use of tail  
Falls to side 
 
VC  Baseline 80 % 20 % 100 % Nil Nil 
7 60 % 40 % 100 % Nil Nil 
14 100 % Nil  100 % Nil Nil 
 
 
TD (1X) 
Baseline 70 % 30 % 100 % Nil Nil 
7 60 % 40 % 100 % Nil Nil 
14 90 % 10 % 100 % Nil Nil 
Table 14: Neurological Examination (Contd..) 
Groups  Days Tail elevation (%)  Static limb 
position (%) 
Abnormal gait 
(%) 
Ataxic gait 
(%)  
Lifts while 
walking 
Occasionally 
lifts 
Limbs normal  None  None  
VC  Baseline 100 % Nil 100 % 100 % 100 % 
7 100 % Nil 100 % 100 % 100 % 
14 100 % Nil 100 % 100 % 100 % 
TD (1X) Baseline 100 % Nil 100 % 100 % 100 % 
7 100 % Nil 100 % 100 % 100 % 
14 100 % Nil 100 % 100 % 100 % 
Table 15: Neurological Examination (Contd..) 
Groups  Days Head Position (%)  Pinna touch response (%)  
Head without 
tilt  
Head With tilt  No 
response  
One 
touch  
More than one 
touch  
VC  Baseline 100 % Nil Nil 80 %  20 % 
7 100 % Nil Nil 80 % 20 % 
14 100 % Nil Nil 70 % 30 % 
 
 
TD (1X) 
Baseline 100 % Nil Nil 80 % 20 % 
7 100 % Nil Nil 50 % 50 % 
14 100 % Nil Nil 70 % 30 % 
Table 16: Clinical Chemistry 
Parameters VC TD (1X) 
7 days(03) 14 days(02) 7 days(05) 14days(05) 
Glucose (mg/dl) 73.0 ± 22.45 - 56.6 ± 18.27 - 
Albumin (g/dl) 3.9 ± 0.21 4.2 ± 0.18 3.1 ± 1.30 3.9 ± 0.26 
Total Protein (g/dl) 6.7 ± 0.54 7.3 ± 0.00 5.7 ± 2.30 6.8 ± 0.53 
Alkaline phosphatase (IU/L) 148.0 ± 28.44 180.5 ± 29.50 163.1 ± 67.72 248.4 ± 66.06 
SGPT (ALT) (U/L) 41.3 ± 4.03 41.5 ± 8.50 36.2 ± 13.33 25.8 ± 4.87 
SGOT (AST) (U/L) 127.3 ± 13.70 153.0 ± 8.00 111.0 ± 40.67 143.8 ± 6.79 
BUN mg/dl 34.7 ± 7.72 42.0 ± 0.00 32.2 ± 11.57 35.2 ± 1.83 
BIT mg/dl 0.1 ± 0.09 0.3 ± 0.03 0.2 ± 0.07 0.2 ± 0.16 
BID mg/dl 0.1 ± 0.03 0.1 ± 0.01 0.1 ± 0.03 0.1 ± 0.06 
( ) = No of animals   Values are mean ± SD 
 
                 Yerranaagu Prasad et. al Pharmaceutical Preparation and Toxicological Study of Rasa Bhasma 
 
 Available online at : http://ijapr.in Page 45 
 
Table 17: Hematology 
Parameters VC TD (1X) 
7 days(03) 14 days(02) 7 days(05) 14 days(05) 
WBCX 103/cu.mm 7.2 ± 2.36 7.9 ± 0.70 6.3 ± 1.36 8.0 ±2.11 
RBCx106/cu.mm 5.4 ± 0.38 5.1 ± 0.28 5.3 ± 0.36 4.9 ± 0.65 
Hemoglobin (g/dl) 11.1 ± 0.65 10.6 ± 0.65 10.8 ± 0.54 9.5 ± 1.40 
HCT % 32.2 ± 2.13 29.6 ± 1.50 30.6 ± 1.70 27.4 ± 4.22 
MCV µ3 59.2 ± 2.14 57.9 ± 0.25 58.1 ± 1.16 55.5 ± 2.12 
PLT X103 544.7 ± 104.38 434.0 ± 50.00 556.8 ± 131.21 422.8 ± 109.85 
Values are expressed as Mean ± SD    ( ) No of animals 
Table 18: Organ Weights (gr.) 
Parameters  7 days 14 days 
VC(03) TD(05) VC(02) TD(05) 
Heart  0.5 ± 0.02 0.5 ± 0.04 0.5 ± 0.00 0.5 ± 0.06 
Kidney (L+R) 1.0 ± 0.07 0.9 ± 0.05 1.0 ± 0.02 0.9 ± 0.09 
Liver  5.6 ± 0.26 4.8 ± 0.48 5.6 ± 0.40 4.9 ± 0.60 
Lung 1.2 ± 0.11 1.1 ± 0.40 1.2 ± 0.04 1.1 ± 0.11 
Spleen 0.9 ± 0.13 0.7 ± 0.12 0.8 ± 0.08 0.8 ± 0.07 
Values are mean ± SD   ( ) No of animals 
Table 19: Necropsy Findings 
DOSAGE VC TD (1X) 
No. of Animals  05 10 
No. dead during treatment 0 0 
No. moribund and sacrificed 0 0 
No. finally sacrificed 5 10 
No. examined for gross pathology 5 10 
No. showing gross pathology 0 0 
Visceral organ pathology X X 
 
Results 
1. No mortality, morbidity, toxic signs, weight loss or 
abnormal behavior were recorded till 14 days 
after 7 days exposure of the test compound of 
recommended therapeutic dose.  
2.  No significant treatment related effect on food 
intake; body weight, clinical signs or behavioral 
activity etc was observed and were compared 
from vehicle group.  
3. No significant changes in hematological 
parameters & clinical chemistry parameters were 
found. 
4.  No specific test compound induced pathological 
changes in various organs were observed. 
Discussion 
As per the toxicological study, due to paucity 
of time an acute toxicity test on swiss albino Rats has 
been planned following the approval of ethical 
committee of Sipra Labs in collaboration with NIN 
Hyderabad under guidance of Dr. B. Dinesh Kumar. The 
drug administration was done in 10.8 mg/kg body 
weight for a period of 7 days via oral route. The vehicle 
of honey and water was given to the control group. 15 
rats have been randomisingly selected and divided into 
two groups as test dose group and vehicle group. In 
both groups, haematological, biochemical 
investigations were carried out at the end of 7 days 
after 48 hrs after last exposure and again after 7 days 
after last exposure, same investigations have been 
carried out apart from the necropsy observations done 
in all organs of animals. It is observed that no 
preterminal deaths occurred and every animal was 
active, there is no loss of body weight. Water intake 
was adequate. In cage side observation they were all 
either resting or sitting and there was no lying on side, 
alert and orient towards investigator and circling 
purposelessly. There was no abnormality in faeces 
output and faeces consistency. Urine output and colour 
was also normal in all animals. In test dose group, in 
the cage side observation there was no change like 
orient towards investigator, aggressiveness or 
vocalisation in the animals. In both the groups there 
was no hair coat change, piloerection and respiratory 
rate. Respiration character, lacrimation and salivation 
were not disturbed. There was no abnormality in eye 
prominence and eyelid closure. There were no 
significant changes in haematological parameters and 
clinical chemistry parameters were found. No specific 
test compound induced pathological changes in 
various organs were observed.  
 Int. J. Ayur. Pharma Research, 2013; 1(2): 38-48                             ISSN 2322 - 0910 
 
 Available online at : http://ijapr.in Page 46 
 
CONCLUSION 
No Pre-terminal deaths occurred in rats 
received test compound at therapeutic dose levels. No 
abnormalities in physical, physiological, clinical 
chemistry, hematological parameters and no gross 
necropsy changes were observed on administration 
(oral) of test compound prepared according to the 
classical literature. At this level of study, it may be 
concluded that Rasa Bhasma is safe as per 
toxicological study and can be subjected for further 
study of clinical evaluation.  
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PREPARATION OF RASA BHASMA 
METHOD – I  
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METHOD – II 
 
   
 
   
 
   
 
   
                                                                                                          
